Engineering a Novel Probiotic Toolkit in Escherichia coli Nissle 1917 for Sensing and Mitigating Gut Inflammatory Diseases
ACS Synthetic Biology · 16.08.2024 · 13 (8) · 2376-2390
DOI: 10.1021/acssynbio.4c00036 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 08.08.2024. Verfasst von Nathalie Weibel und 19 weiteren Autor:innen. Beteiligte Einrichtung: University of Zürich, Campus Irchel Winterthurerstrasse 190, 8057 Zürich, Switzerland. Hauptthemen laut MEDLINE: Probiotics, Escherichia coli, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Les Laboratories Pierre Fabre, Promega, Akademie der Naturwissenschaften.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation with no cure and limited treatment options that often have systemic side effects. In this study, we developed a target-specific system to potentially treat IBD by engineering the probiotic bacterium Escherichia coliNissle 1917 (EcN). Our modular system comprises three components: a transcription factor-based sensor (NorR) capable of detecting the inflammation biomarker nitric oxide (NO), a type 1 hemolysin secretion system, and a therapeutic cargo consisting of a library of humanized anti-TNFα nanobodies. Despite a reduction in sensitivity, our system demonstrated a concentration-dependent response to NO, successfully secreting functional nanobodies with binding affinities comparable to the commonly used drug Adalimumab, as confirmed by enzyme-linked immunosorbent assay and in vitro assays. This newly validated nanobody library expands EcN therapeutic capabilities. The adopted secretion system, also characterized for the first time in EcN, can be further adapted as a platform for screening and purifying proteins of interest. Additionally, we provided a mathematical framework to assess critical parameters in engineering probiotic systems, including the production and diffusion of relevant molecules, bacterial colonization rates, and particle interactions. This integrated approach expands the synthetic biology toolbox for EcN-based therapies, providing novel parts, circuits, and a model for tunable responses at inflammatory hotspots.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Zürich, Campus Irchel Winterthurerstrasse 190, 8057 Zürich, Switzerland.
- Institute of Pharmacology and Toxicology, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
- Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
- Institute of Medical Microbiology, University of Zürich, Gloriastrasse 28/30, CH-8006 Zürich, Switzerland.
- Department of Gastroenterology and Hepatology, University Hospital Zürich and Zürich University, Rämistrasse 100, 8091 Zurich, Switzerland.
- Department of Evolutionary Biology and Environmental Studies, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
ORCID-Profile: Nathalie Weibel, Fabian Ackle, Cauã Antunes Westmann
Förderung
- Les Laboratories Pierre Fabre
- Promega
- Akademie der Naturwissenschaften
- Universität Zürich
- Consortium of Swiss Academic Libraries
- Microsynth
Zitieren
APA
Weibel, N., Curcio, M., Schreiber, A., Arriaga, G., Mausy, M., Mehdy, J., Brüllmann, L., Meyer, A., Roth, L., Flury, T., Pecina, V., Starlinger, K., Dernič, J., Jungfer, K., Ackle, F., Earp, J., Hausmann, M., Jinek, M., Rogler, G., & Antunes Westmann, C. (2024). Engineering a Novel Probiotic Toolkit in Escherichia coli Nissle 1917 for Sensing and Mitigating Gut Inflammatory Diseases. ACS Synthetic Biology, 13(8), 2376-2390. https://doi.org/10.1021/acssynbio.4c00036
Vancouver
Weibel N, Curcio M, Schreiber A, Arriaga G, Mausy M, Mehdy J, et al. Engineering a Novel Probiotic Toolkit in Escherichia coli Nissle 1917 for Sensing and Mitigating Gut Inflammatory Diseases. ACS Synthetic Biology. 2024;13(8):2376-2390. doi:10.1021/acssynbio.4c00036
BibTeX
@article{Weibel2024,
author = {Weibel, Nathalie and Curcio, Martina and Schreiber, Atilla and Arriaga, Gabriel and Mausy, Marine and Mehdy, Jana and Brüllmann, Lea and Meyer, Andreas and Roth, Len and Flury, Tamara and Pecina, Valerie and Starlinger, Kim and Dernič, Jan and Jungfer, Kenny and Ackle, Fabian and Earp, Jennifer and Hausmann, Martin and Jinek, Martin and Rogler, Gerhard and Antunes Westmann, Cauã},
title = {Engineering a Novel Probiotic Toolkit in Escherichia coli Nissle 1917 for Sensing and Mitigating Gut Inflammatory Diseases},
journal = {ACS Synthetic Biology},
year = {2024},
volume = {13},
number = {8},
pages = {2376--2390},
doi = {10.1021/acssynbio.4c00036}
}
EUVIMED